Who owns Lexicon Pharmaceuticals?

Key details on Lexicon Pharmaceuticals (Ticker: LXRX)

Who owns Lexicon Pharmaceuticals?

Is LXRX a good stock to own? Find out who bought Lexicon Pharmaceuticals, who sold Lexicon Pharmaceuticals (LXRX) stock, and who holds a large position in Lexicon Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
Artal Group S.A. 253.37M $603.03M Sept. 30, 2013
FMR 74.72M $134.50M Dec. 31, 2013
Ulys 29.78M $70.88M Sept. 30, 2013
UBS GLOBAL ASSET MANAGEMENT AMERICAS 17.84M $31.93M Dec. 31, 2013
Vanguard 13.35M $24.04M Dec. 31, 2013
NEA Management Company 11.68M $21.02M Dec. 31, 2013
BlackRock Fund Advisors 11.62M $20.92M Dec. 31, 2013
BlackRock Institutional Trust Company, N.A. 7.19M $12.94M Dec. 31, 2013
STATE STREET CORPORATION 6.78M $12.21M Dec. 31, 2013
T. Rowe Price Associates 6.48M $11.67M Dec. 31, 2013
Royce & Associates 4.23M $7.62M Dec. 31, 2013
Invus Public Equities Advisors 3.89M $6.85M June 30, 2011
Schroder Investment Management 3.36M $6.05M Dec. 31, 2013
NORTHERN TRUST 3.26M $5.87M Dec. 31, 2013
Perceptive Advisors 3.20M $6.97M March 31, 2013
JPMORGAN CHASE & CO 2.92M $6.57M June 30, 2012
Norges Bank Investment Management 2.54M $4.57M Dec. 31, 2013
Jefferies 2.13M $3.80M Dec. 31, 2013
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY 2.08M $3.60M March 31, 2014
Gabelli Funds 1.83M $3.29M Dec. 31, 2013
Allianz Asset Management AG 1.68M $3.64M June 30, 2013
Geode Capital Management 1.65M $3.92M Sept. 30, 2013
Howard Hughes Medical Institute 1.24M $2.88M Sept. 30, 2012
Franklin Resources 985408 $1.77M Dec. 31, 2013
TIAA-CREF Investment Management 938773 $2.04M June 30, 2013

Who sold Lexicon Pharmaceuticals?

Fund Name Date Sold Number of Shares Sold Share Valuation
Driehaus Capital Management June 30, 2011 1.23M $2.16M
Oracle Investment Management Dec. 31, 2010 1.09M $1.57M